XML 30 R17.htm IDEA: XBRL DOCUMENT
v3.19.1

SHAREHOLDERS' EQUITY | 12 Months Ended
--- | ---
Dec. 31, 2018
Stockholders' Equity Attributable to Parent [Abstract] |
SHAREHOLDERS' EQUITY |
NOTE 11:- | SHAREHOLDERS' EQUITY
| a. | Authorized, issued and outstanding share capital in historical terms is as follows:
|  | Authorized |  |  | Issued and outstanding |
|  | December 31 |  |  | December 31, |
|  | 2018 and 2017 |  |  | 2018 |  |  |  | 2017*) |
|  | Number of shares |
Ordinary shares of par value NIS 3.0 each |  |  | 10,000,000 |  |  |  | 2,028,552 |  |  |  | 2,028,552 |
Ordinary shares of par value NIS 3.0 each amount in US$ |  |  |  |  |  |  | 397,056 |  |  |  | 397,056 |
| *) | Respectively adjusted to reflect reverse split of shares.
| b. | Stock Option Plan:
The Company’s 2018 Share Incentive Plan (the "Plan") authorized the grant of options to purchase shares and restricted shares unites (“RSUs”) to officers, employees, directors and consultants of the Company and its Subsidiaries. Awards granted under the Plan to participants in various jurisdictions may be subject to specific terms and conditions for such grants as may be approved by the Company’s board from time to time. Each option granted under the Plan is exercisable for a period of ten years from the date of the grant of the option or the expiration dates of the option plan. The options primarily vest gradually over four years of employment. During July 2018 the Company granted 60,857 options to the Company’s CEO to acquire 60,857 Ordinary shares under the Plan. The total fair value of the options granted was $183 to be recognized over four years vesting period. The stock-based compensation expense related to employees' equity-based awards, recognized during 2018 was $56. A summary of employee option activity under the Plan as of December 31, 2018 and changes during the year ended December 31, 2018 are as follows:
|  | Number of options |  |  | Weighted-average exercise price |  |  | Weighted- average remaining contractual life (in months) |  |  | Aggregate intrinsic value (in thousands) |
Outstanding at January 1, 2018 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Granted |  |  | 60,857 |  |  |  | 4.17 |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2018 |  |  | 60,857 |  |  |  | 4.17 |  |  |  | 114 |  |  |  | - |
Exercisable at December 31, 2018 |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
The weighted-average grant-date fair value of options granted during the years ended December 31, 2018 were $ 4.17. No options were granted in 2017 and 2016. The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company's closing stock price on the last trading day of the fourth quarter of fiscal 2018 and the exercise price, multiplied by the number of in-the-money options). This amount changes, based on the fair market value of the Company's stock. As of December 31, 2018, there was approximately $ 127 of unrecognized compensation costs related to non-vested share-based compensation arrangements granted under the Company's stock option plans. This cost is expected to be recognized over a period of up to 3.5 years. The options outstanding as of December 31, 2018 are follows:
Number of options outstanding as of December 31, 2018 |  |  | Exercise price |  |  | Weighted average remaining contractual life |  |  | Number of options exercisable as of December 31, 2018 |
|  |  |  |  |  | (In months) |  |  |  |
| 60,857 |  |  |  | 4.17 |  |  |  | 114 |  |  |  | - |

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration